Nilai Dipunlarasaken Utang lan Kas Innate Pharma S.A (IPHA)

The market capitalization trend for Innate Pharma S.A. (IPHA) on the GURU.Markets platform is 175.96, supported by a stable moat derived from its innate immunity activation platform and licensing fees. The French developer dictates payment terms thanks to exclusive patents and alliances with market leaders. High barriers to entry are created by antibody patents and stringent oversight from the EMA and FDA.

IPHA (Innate Pharma S.A.) riwayat Nilai Total Perusahaan saka 23.11.2025 nganti 28.10.2026

Innate Pharma S.A. - rincian analitis lan metrik utama (IPHA)

- rega lan prakiraan konsensus rega:

Bagan kutipan Innate Pharma SA|IPHA - Prakiraan konsensus analis

- data kapitalisasi pasar:

Nilai pasar Innate Pharma|IPHA - Nilai Perusahaan

- data kapitalisasi buku:

Nilai Buku saben Saham Innate Pharma|IPHA - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku innate-pharma.com|IPHA - Aset Agregat Perusahaan

- data utang lan likuiditas:

Rasio Utang marang Ekuitas Innate Pharma S.A.|IPHA - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas innate-pharma.com|IPHA - Utang perusahaan|Utang-utang marang nilai buku Innate Pharma

Pambiji fundamental:Innate Pharma SA (IPHA)

Enterprise value represents the total acquisition cost of an asset, combining market capitalization and net debt, which allows for an assessment of the actual costs of buying out a business. By analyzing the aggregate valuation of Innate Pharma S.A. (IPHA), an investor can see how high R&D expenditures on laboratories are balanced by strategic partnerships, determining a fair value threshold relative to capital drawdown risks.

Pesaing Innate Pharma S.A. (IPHA)

Nilai Wutuh Bisnis ImmunityBio Inc IBRX|Nilai Perusahaan Immunocore PLC (IMCR)|JANX - Nilai Dipunlarasaken Utang lan Kas|RCUS: Nilai Perusahaan|ZYME (zymeworks.com) - Nilai Perusahaan|Nilai Total Perusahaan TNGX (Tango Therapeutics, Inc.)|Total Nilai Perusahaan IOVA|Nilai Total Perusahaan Immatics Corp IMTX|Nilai Bisnis Xencor Inc. (XNCR)|Compass Therapeutics - Nilai Perusahaan|replimune.com - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|LYEL (Lyell Immunopharma, Inc.) - Nilai Total Perusahaan|PYXS: Total Nilai Perusahaan|cgen.com (CGEN) - Nilai Total Perusahaan|IOBT (IO Biotech Inc.) - Nilai Total Perusahaan|Nilai Total Perusahaan STRO (Sutro Biopharma, Inc.)|Total Nilai Perusahaan minktherapeutics.com|HOWL: Nilai Perusahaan|Nilai Perusahaan Nalika Diakuisisi Penuh immixbio.com IMMX|ALXO: Rega Nyata Tumbas Perusahaan Kanthi Wutuh|CUE - Total Nilai Perusahaan|Rega Nyata Tumbas Perusahaan Kanthi Wutuh PDS Biotechnology Corp (PDSB)|SONN - Nilai Dipunlarasaken Utang lan Kas|MAIA Biotechnology, Inc. - Nilai Perusahaan|LIMN (Liminatus Pharma Inc.) - Rega Tumbas Perusahaan|Nilai Total Perusahaan LVTX|Rega Nyata Tumbas Perusahaan Kanthi Wutuh NXTC|Nilai Total Perusahaan LPTX (Leap Therapeutics, Inc.)|Rega Nyata Tumbas Perusahaan Kanthi Wutuh intensitytherapeutics.com INTS|Rega Nyata Tumbas Perusahaan Kanthi Wutuh SNSE (Sensei Biotherapeutics, Inc.)|Theriva Biologics Inc - Nilai Perusahaan|Gritstone Bio (GRTS) - Nilai Total Perusahaan|KA: Nilai Bisnis|Nilai Total Perusahaan NEXI|Total Nilai Perusahaan Turnstone Biologics Corp.|Vaccinex - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Nilai Perusahaan Nalika Diakuisisi Penuh Harpoon Therapeutics Inc (HARP)